Category - Feature

Feature

BerGenBio pioneering cutting-edge AXL therapies to fight aggressive diseases

BerGenBio (OSE:BGBIO) is developing a pipeline of transformative drugs targeting AXL as a cornerstone of therapy for aggressive diseases, including cancer and severe respiratory infections.

July 16, 2024

Feature

Perimeter aims to transform cancer surgery with ultra-high-res imaging tools

Perimeter Medical Imaging AI (TSX:PINK; OTC:PYNKF; FSE:4PC) is developing breakthrough ultra-high-resolution, real-time, advanced imaging tools to assist cancer surgeons in achieving clean margins during initial surgery.

July 2, 2024

Feature

Candel enhancing cancer patient survival and quality of life with breakthrough viral immunotherapies

Candel Therapeutics (NASDAQ:CADL) is developing off-the-shelf multimodal viral immunotherapies for individualized systemic anti-tumor immune response, specific to the patient’s difficult-to-treat cancer, improving...

June 25, 2024

Feature

Vizgen championing the power of spatial genomics with unprecedented transformative insight into biological systems

Closely-held Vizgen is pioneering next-generation genomics and benchmarking the spatial genomics field with its commercial MERSCOPE Platform, the industry’s first high plex in situ single-cell spatial genomics solution...

May 7, 2024

Feature

BioRestorative Therapies propelling cell-based therapies for lower back pain, Obesity, Type 2 diabetes and more

BioRestorative Therapies (NASDAQ:BRTX) is a fully integrated regenerative medicine company with preclinical and Phase 2 clinical programs focused on conditioning the bodies’ regenerative potential to treat major...

March 5, 2024

Feature

TriSalus developing novel therapeutic solutions for liver and pancreatic tumors

TriSalus Life Sciences (NASDAQ:TLSI) is addressing the mechanical and biologic barriers within the tumor microenvironment (TME) that make it challenging to successfully treat liver and pancreatic tumors.

January 9, 2024

Feature

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Closely-held xNARA Biologics is reshaping the wellness industry through personalized health and wellness solutions designed to address genetic predispositions and disorders identified by analyzing individual DNA, gut...

January 9, 2024

Feature

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Closely-held Simtra BioPharma Solutions, a premier contract development and manufacturing organization with more than 65 years of sterile injectable manufacturing experience, offers world-class cGMP sterile fill/finish...

December 19, 2023

Feature

Bridging clinical trial diversity gaps and accelerating R&D in rare disease

As founder and executive chair of the non-profit Indo-US Organization for Rare Disease (IndoUSrare), Harsha Rajasimha, Ph.D., social entrepreneur, and subject matter expert in bioinformatics, data analysis, and...

December 12, 2023

Feature

Personalis developing patient-specific test for earlier cancer detection

Personalis (NASDAQ:PSNL) is developing a liquid biopsy assay designed to detect minimal residual disease (MRD) and cancer recurrence earlier than other diagnostic methods.

December 5, 2023

Category - Feature

Subscribe